MIT BOTULINUMTOXIN VORGEFÜLLTE SPRITZE
European patent · EP3253364 · In force
Register entry
- Publication number
- EP3253364
- Application number
- EP15820043
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 22, 2015
- Published
- Dec 13, 2017
- Granted
- Jul 2, 2025
- Protection ends at the latest
- Dec 21, 2035
- Next annual fee due
- Dec 31, 2026
- IPC classes
- A61K 9/00 (2006.01)A61K 38/48 (2006.01)A61K 47/26 (2006.01)A61Q 19/08 (2006.01)A61M 5/31 (2006.01)A61K 8/64 (2006.01)A61M 5/315 (2006.01)A61P 15/18 (2006.01)A61P 25/08 (2006.01)A61P 25/14 (2006.01)A61P 17/00 (2006.01)A61P 43/00 (2006.01)A61P 17/02 (2006.01)A61P 21/00 (2006.01)A61P 25/06 (2006.01)A61P 25/04 (2006.01)A61P 25/02 (2006.01)A61P 25/00 (2006.01)
- Priority
- EP 15000310 03.02.2015
- PCT application
- PCT/EP2015/002600 22.12.2015
- PCT publication
- WO2016/124213 11.08.2016
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 18, 2026
Change
Published in Swissreg on 18.05.2026
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Jul 2, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 02.07.2025
Parties
Inventor
VOGT, Markus
60438 Frankfurt am Main, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.